Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer
Titel:
Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer
Auteur:
Li, Xin Yang, Changyong Wan, Hong Zhang, Ge Feng, Jun Zhang, Lei Chen, Xiaoyan Zhong, Dafang Lou, Liguang Tao, Weikang Zhang, Lianshan